These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19283713)

  • 1. Th17: The ascent of a new effector T-cell subset. Preface.
    Weaver CT
    Eur J Immunol; 2009 Mar; 39(3):634-6. PubMed ID: 19283713
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouse Th17 cells: current understanding of their generation and regulation.
    Dong C
    Eur J Immunol; 2009 Mar; 39(3):640-4. PubMed ID: 19283704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of T helper and T regulatory cell responses at birth.
    Schaub B; Liu J; Schleich I; Höppler S; Sattler C; von Mutius E
    Allergy; 2008 Nov; 63(11):1438-47. PubMed ID: 18925880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells in health and disease.
    Akdis CA
    J Allergy Clin Immunol; 2009 May; 123(5):1022-3. PubMed ID: 19410690
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of the Th17 pathway and its role in host defense.
    O'Quinn DB; Palmer MT; Lee YK; Weaver CT
    Adv Immunol; 2008; 99():115-63. PubMed ID: 19117534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental plasticity of Th17 and Treg cells.
    Lee YK; Mukasa R; Hatton RD; Weaver CT
    Curr Opin Immunol; 2009 Jun; 21(3):274-80. PubMed ID: 19524429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands.
    Stockinger B; Veldhoen M; Hirota K
    Eur J Immunol; 2009 Mar; 39(3):652-4. PubMed ID: 19283715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Th17 cells: are they different from murine Th17 cells?
    Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
    Eur J Immunol; 2009 Mar; 39(3):637-40. PubMed ID: 19283714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Immune Regulation Meeting (WIRM)--III: special focus on regulatory and effector mechanisms.
    Godoy L
    Drug News Perspect; 2009 Dec; 22(10):623-6. PubMed ID: 20140282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cytokines and mucosal immunity.
    Dubin PJ; Kolls JK
    Immunol Rev; 2008 Dec; 226():160-71. PubMed ID: 19161423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasites and autoimmunity: the case of fungi.
    Romani L
    Autoimmun Rev; 2008 Dec; 8(2):129-33. PubMed ID: 18703172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
    Gyülvészi G; Haak S; Becher B
    Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17/Th17 in anti-fungal immunity: what's new?
    Zelante T; De Luca A; D'Angelo C; Moretti S; Romani L
    Eur J Immunol; 2009 Mar; 39(3):645-8. PubMed ID: 19283705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
    Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
    Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic targets along the Th17 pathway.
    Ouyang W; Filvaroff E; Hu Y; Grogan J
    Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and function of TH17 cells in health and disease.
    Louten J; Boniface K; de Waal Malefyt R
    J Allergy Clin Immunol; 2009 May; 123(5):1004-11. PubMed ID: 19410689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 T cells: linking innate and adaptive immunity.
    Stockinger B; Veldhoen M; Martin B
    Semin Immunol; 2007 Dec; 19(6):353-61. PubMed ID: 18023589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.